COVID-19: pathogenetic aspects
DOI: https://doi.org/10.29296/25877305-2022-10-01
Issue:
10
Year:
2022
Understanding the pathogenetic aspects of COVID-19, which affect the development of the disease and its complications, will be able to improve the medical care provided.
The paper considers a relationship between the trigger of release of pro-inflammatory cytokines and the development of infiltration in endothelial cells and between microvascular dysfunction and an increase in respiratory failure. Based on the data available in the literature, the authors describe the trigger of respiratory tract diseases and multiple organ failure, which contribute to COVID-19 progression
Keywords:
infectious diseases
COVID-19
SARS-CoV-2
pathogenesis
References:
- Shakmaeva M.A., Chernova T.M., Timchenko V.N. et al. Features of a new Coronavirus infection in children of different ages. Children Infections. 2021; 20 (2): 5–9 (in Russ.). DOI: 10.22627/2072-8107-2021-20-2-5-9
- Lvov D.K., Alkhovsky S.V. Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus). Problems of Virology. 2020; 65 (2): 62–70 (in Russ.). DOI: 10.36233/0507-4088-2020-65-2-62-70
- Rumyantsev A.G. Coronavirus infection COVID-19. Scientific challenges and possible ways to treat and prevent the disease. Russian Journal of Pediatric Hematology and Oncology. 2020; 7 (3): 47–53 (in Russ.). DOI: 10.21682/2311-1267-2020-7-3-47-53
- Nikiforov V.V., Suranova T.G., Chernobrovkina T.Yu. et al. New Coronavirus Infection (COVID-19): Clinical and Epidemiological Aspects. The Russian Archives of Internal Medicine. 2020; 10 (2): 87–93 (in Russ.). DOI: 10.20514/2226-6704-2020-10-2-87-93
- Wang K., Chen W., Zhou Y.S. et al. SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. BioRxiv. 2020. DOI: 10.1101/ 2020.03.14.988345
- Kozlov V.A., Tikhonova E.P., Savchenko A.A. et al. Klinicheskaya immunologiya. Prakticheskoe posobie dlya infektsionistov. Krasnoyarsk: Polikor, 2021; 563 р. DOI: 10.17513/np.518
- Ryazanov V., Kutsenko V., Sadykova S. et al. Features of computed tomography in diagnostics COVID-19. Vrach. 2022; 33 (4): 53–5 (in Russ.). DOI: 10.29296/25877305-2022-04-07
- Wang X., Zheng J., Guo L. et al. Fecal viral shedding in COVID-19 patients: Clinical significance, viral load dynamics and survival analysis. Virus Res. 2020; 289: 198147. DOI: 10.1016/j.virusres.2020.198147
- Kudlay D., Shirobokov Ya., Gladunova E. et al. Diagnosis of COVID-19. Methods and problems of virus SARS-CoV-2 detection under pandemic conditions. Vrach. 2020; 31 (8): 5–10. DOI: 10.29296/25877305-2020-08-01
- The team of Zhong Nanshan responded that the isolation of SARS-CoV-2 from urine remind us to pay more attention to the cleaning of individuals and families. Guangzhou Daily. Published February, 2020; 22.
- Murkamilov I., Aitbaev K., Fomin V. et al. New coronavirus infection (COVID-19) and nephro-cerebrovascular system. The scientific heritage. 2020; 46: 42–9 (in Russ.).
- Namazova-Baranova L.S., Baranov A.A. COVID-19 and children. Pulmonologiya. 2020; 30 (5): 609–28 (in Russ.). DOI: 10.18093/0869-0189-2020-30-5-609-628
- Ling Y., Xu S.B., Lin Y.X. et al. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J (Engl). 2020; 133 (9): 1039–43. DOI: 10.1097/CM9.0000000000000774
- Li Y.C., Bai W.Z., Hashikawa T. The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020; 92 (6): 552–5. DOI: 10.1002/jmv.25728
- Kuster G.M., Pfister O., Burkard T. et al. SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in pa-tients with COVID-19? Eur Heart J. 2020; 41 (19): 1801–3. DOI: 10.1093/eurheartj/ehaa235
- Oudit G.Y., Kassiri Z., Jiang C. et al. SARS-coronavirus modulation of myocardial АПФ2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2009; 39 (7): 618–25. DOI: 10.1111/j.1365-2362.2009.02153.x
- Baig A.M., Khaleeq A., Ali U. et al. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem Neurosci. 2020; 11 (7): 995–8. DOI: 10.1021/acschemneuro.0c00122
- Kimura H., Francisco D., Conway M. et al. Type 2 inflammation modulates АПФ2 and TMPRSS2 in airway epithelial cells. J Allergy Clin Immunol. 2020; 146 (1): 80–88.e8. DOI: 10.1016/j.jaci.2020.05.004
- Khera R., Clark C., Lu Y. et al. Association of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers with the risk of hospitalization and de at hinhypertensive patients with coronavirus disease-19. Med Rxiv. 2020; 2020.05.17.20104943. DOI: 10.1101/2020.05.17.20104943 [Preprint].
- WebMD. Coronavirus in kids and babies. Available at: https://www.webmd.com/lung/coronavirus-covid-19-babies-children#1
- Short K.R., Kroeze E.J.B.V., Fouchier R.A.M. et al. Pathogenesis of influenza-induced acute respiratory distress syndrome. Lancet Infect Dis. 2014; 14 (1): 57–69. DOI: 10.1016/ S1473-3099(13)70286-X
- Chesnokova N.P., Morrison V.V., Brill' G.E. et al. Lektsiya 7. Dykhatel'naya nedostatochnost', razvivayushchayasya pri narushenii diffuzionnoi sposobnosti legkikh. Patologiya al'veolyarnogo dykhaniya. Scientific review. Medical sciences. 2017; 2: 46–8 (in Russ.). URL: https://science-medicine.ru/ru/article/view?id=976
- Huang C., Wang Y., Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395 (10223): 497–506. DOI: 10.1016/S0140-6736(20)30183-5
- Shi H., Han X., Jiang N. et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020; 20 (4): 425–34. DOI: 10.1016/S1473-3099(20)30086-4
- Voronina T.A. Antioxidants/antihypoxants: the missing puzzle piece in effective pathogenetic therapy for COVID-19. Infectious diseases. 2020; 18 (2): 97–102 (in Russ.). DOI: 10.20953/1729-9225-2020-2-97-102
- Yi Y., Lagniton P.N.P., Ye S. et al. COVID-19: what has been learned and to be learned about the novel corona virus disease. Int J Biol Sci. 2020; 16 (10): 1753–66. DOI: 10.7150/ijbs.45134
- Gorodin V.N., Moysova D.L., Zotov S.V. et al. Role of polymorphisms of genes involved in hemostasis in COVID-19 pathogenesis. Infectious diseases. 2021; 19 (2): 16–26 (in Russ.). DOI: 10.20953/1729-9225-2021-2-16-26
- Iba T., Warkentin T.E., Thachil J. et al. Proposal of the Definition for COVID-19-Associated Coagulopathy. J Clin Med. 2021; 10 (2): 191. DOI: 10.3390/jcm10020191
- Wool G.D., Miller J.L. The Impact of COVID-19 Disease on Platelets and Coagulation. Pathobiology. 2021; 88 (1): 15–27. DOI: 10.1159/000512007
- Léonard-Lorant I., Delabranche X., Séverac F. et al. Acute Pulmonary Embolism in Patients with COVID-19 at CT Angiography and Relationship to d-Dimer Levels. Radiology. 2020; 296 (3): 189–91. DOI: 10.1148/radiol.2020201561
- Carsana L., Sonzogni A., Nasr A. et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis. 2020; 20 (10): 1135–40. DOI: 10.1016/S1473-3099(20)30434-5
- Fox S.E., Akmatbekov A., Harbert J.L. et al. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. Lancet Respir Med. 2020; 8 (7): 681–6. DOI: 10.1016/S2213-2600(20)30243-5
- Wichmann D., Sperhake J.P., Lütgehetmann M. et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Ann Intern Med. 2020; 173 (4): 268–77. DOI: 10.7326/M20-2003
- Simbirtsev A.S. Oytokines in the pathogenesis of infectious and noninfectious human diseases. Medical Academic Journal. 2013; 13 (3): 18–41 (in Russ.). DOI: 10.17816/MAJ13318-41
- Ngu S.C., Tilg H. COVID-19 and the gastrointestinal tract: more than meets the eye. Gut. 2020; 69 (6): 973–4. DOI: 10.1136/gutjnl-2020-321195
- Chen N., Zhou M., Dong X. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395 (10223): 507–13. DOI: 10.1016/S0140-6736(20)30211-7
- Tan W., Aboulhosn J. The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease. Int J Cardiol. 2020; 309: 70–7. DOI: 10.1016/j.ijcard.2020.03.063
- Dedov D. Novel coronavirus infection (COVID-19): epidemiology, clinical characteristics of patients, risk of complications, prevention, use of selenium-containing drugs. Vrach. 2022; 33 (5): 58–62 (in Russ.). DOI: 10.29296/25877305-2022-05-12
- Bazdyrev E.D. Coronavirus disease: a global problem of the 21st century. Complex Issues of Cardiovascular Diseases. 2020; 9 (2): 6–16 (in Russ.). DOI: 10.17802/2306-1278-2020-9-2-6-16
- Veber V.R., Fishman B.B., Kulikov V.E. et al. Variants of associations kliniko-biochemical parameters and cytokines at cirrhosis of liver of viral etiology at of the various levels of portal pressure. HIV Infection and Immunosuppressive Disorders. 2018; 10 (1): 47–53 (in Russ.). DOI: 10.22328/2077-9828-2018-10-1-47-53
- Zang R., Gomez Castro M.F., McCune B.T. et al. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Sci Immunol. 2020; 5 (47): eabc3582. DOI: 10.1126/sciimmunol.abc3582
- Gemmati D., Tisato V. Genetic Hypothesis and harmacogenetics Side of Renin-Angiotensin-System in COVID-19. Genes (Basel). 2020; 11 (9): 1044. DOI: 10.3390/genes11091044
- Petrazzuolo A., Le Naour J., Vacchelli E. et al. No impact of cancer and plague-relevant FPR1 polymorphisms on COVID-19. Onco-immunology. 2020; 9 (1): 1857112. DOI: 10.1080/2162402X.2020.1857112
- Wenzhong L., Hualan L. COVID-19: Attacksthe1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism. URL: https://chemrxiv.org/articles/COVID19_Disease_ORF8_and_Surface_Glycoprotein_Inhibit_Heme_Metabolism_by_Binding_to_Porphyrin/11938173
- Borodulina E.A., Vasneva Zh.P., Borodulin B.E. et al. Hematological indicators for lung damage caused by COVID-19 infection. Russian Clinical Laboratory Diagnostics. 2020; 65 (11): 676–82 (in Russ.). DOI: 10.18821/0869-2084-2020-65-11-676-682
- Borodulina E.A., Vasneva Z.P., Vdoushkina E.S. et al. Features of Hematological and Hemostasiological Parameters in Coronavirus Infection COVID-19 and Community-Acquired Pneumonia. Acta Biomedica Scientifica. 2021; 6 (1): 40–7 (in Russ.). DOI: 10.29413/ABS.2021-6.1.6
- Borodulina E.A., Yakovleva E.V., Povalyaeva L.V. et al. Comparative study of the serum hepcidin level of patients with pneumonia in COVID-19 and pneumocystis pneumonia. Russian Clinical Laboratory Diagnostics. 2021; 66 (11): 645–9 (in Russ.). DOI: 10.51620/0869-2084-2021-66-11-645-649